Weekly ReportSep 21–27, 2026
Sepsis, week 39 edition
We read 266 papers and selected 3.
Summary
This week’s sepsis literature emphasized actionable infection prevention, endothelial and immune mechanisms, and increasingly individualized prediction and treatment. Genomic epidemiology identified sinks, ward surfaces, oxygen equipment, cots, and maternal hands as important reservoirs for ESBL-producing Klebsiella pneumoniae transmission in a neonatal unit. Mechanistic studies linked oxidized cell-free hemoglobin to glycocalyx destruction and identified LAPTM5-regulated macrophage autophagy as a potential therapeutic pathway in septic lung injury. Clinical research also supported balanced crystalloids as physiologically preferable without mortality benefit in children, highlighted immune-informed antibiotic dosing and novel agents for resistant infections, and demonstrated growing value—but ongoing validation requirements—for AI and biomarker-based risk stratification.
Selected Articles
1. Transmission of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in a Malawian neonatal unit: a clinical and genomic analysis of a prospective cohort study.
In a prospective cohort of 94 mother-neonate pairs, 49% of neonates became colonized with ESBL-producing Klebsiella pneumoniae. Whole-genome sequencing and transmission modeling implicated ward surfaces, especially sinks and oxygen-delivery equipment, as major reservoirs, with additional contributions from cots, maternal hands, and other neonates.
Impact: The study directly connected clinical, environmental, and invasive isolates through genomic epidemiology and converted transmission findings into specific infection-control targets in a resource-constrained neonatal setting.
Clinical Implications: Neonatal units should prioritize sink and surface decontamination, stool containment, cot cleaning, maternal hand hygiene, and dedicated or single-use oxygen-delivery equipment. Prospective implementation studies are needed to prove reductions in invasive infection and mortality.
Key Findings
- Among 90 evaluable neonates, 44 (49%) were colonized with ESBL-producing K. pneumoniae.
- Approximately 37%-65% of transmission was attributed to ward surfaces, with sinks and oxygen equipment prominent.
- Seventy-six percent of invasive isolates clustered genetically with stool or environmental isolates.
2. Cell-free hemoglobin upregulates pulmonary endothelial heparanase expression to drive glycocalyx destruction and inflammation in sepsis.
Using human sepsis samples, murine peritonitis, endothelial heparanase deletion, and human pulmonary endothelial cells, the study identified a cell-free hemoglobin–heparanase pathway driving endothelial glycocalyx degradation and inflammation. Oxidized cell-free hemoglobin increased heparanase expression and activation, whereas endothelial heparanase deletion or acetaminophen attenuation reduced glycocalyx injury and inflammatory effects.
Impact: The study provides convergent human, animal, genetic, and cellular evidence for a mechanistic link between hemolysis-related cell-free hemoglobin and endothelial barrier failure, identifying a plausible therapeutic axis.
Clinical Implications: Therapies that reduce oxidized cell-free hemoglobin or inhibit endothelial heparanase could potentially preserve the glycocalyx and reduce organ injury, but biomarker validation, clinically relevant dosing, and post-sepsis intervention studies are required.
Key Findings
- Higher circulating cell-free hemoglobin was associated with increased heparanase and heparan sulfate levels and adverse outcomes in human sepsis.
- Cell-free hemoglobin caused pulmonary endothelial glycocalyx degradation and systemic and pulmonary inflammation in experimental models.
- Endothelial heparanase deletion abrogated the harmful effects of cell-free hemoglobin.
3. LAPTM5 Downregulation-Driven VAMP8 Phosphorylation Impairs Autophagosome-Lysosome Fusion and Aggravates Septic Acute Lung Injury.
Using patient samples, septic mouse models, macrophage-specific depletion, and viral rescue, the study identified LAPTM5 as a regulator of macrophage autophagic homeostasis. LAPTM5 scaffolds PGAM5 and VAMP8, promotes VAMP8 dephosphorylation and autophagosome–lysosome fusion, clears damaged mitochondria, and reduces oxidative stress and inflammatory lung injury.
Impact: The study offers a coherent, experimentally supported explanation for how defective macrophage autophagy amplifies septic acute lung injury and identifies LAPTM5 as a potentially actionable target.
Clinical Implications: LAPTM5 expression and the associated autophagy pathway may eventually support risk stratification or targeted therapy for septic acute lung injury. The findings remain preclinical and do not yet justify changes to standard sepsis or acute lung injury management.
Key Findings
- LAPTM5 was downregulated in septic acute lung injury patient samples and septic mouse alveolar macrophages, correlating inversely with SOFA score.
- Macrophage-specific Laptm5 depletion worsened, whereas Laptm5 overexpression improved, septic lung injury in mice.
- LAPTM5 promoted PGAM5-dependent VAMP8 dephosphorylation, autophagosome–lysosome fusion, mitochondrial clearance, and reduced inflammation.